Business · 06/03/2007

FDA Amends Monograph for OTC Dandruff, Seborrheic Dermatitis, and Psoriasis Treatments

The Food and Drug Administration (FDA) has finalized a rule adding a new shampoo treatment to its monograph for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis medications, which combines 1.8 percent coal tar solution and 1.5 percent menthol to control dandruff, following no public comments or data on the proposed rule.